benzo[d]isothiazol-3-one

We are benzo[d]isothiazol-3-one CAS:2634-33-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: benzo[d]isothiazol-3-one
CAS.NO:  2634-33-5
Synonyms:
2,3-dihydro-3-oxo-1,2-benzisothiazole
Benzocil
Proxan
1,2-benzisothiazol-3-one
1,2-Benzisothiazol-3(2H)-one

Molecular Formula: C7H5NOS
Molecular Weight:  151.18600

Physical and Chemical Properties:
Density: 1.367g / cm3
Boiling point: 204.5ºC at 760 mmHg
Melting point: 154-158ºC
Flash point: 77.5ºC
Refractive index: 1.66

Specification:
Appearance: White or Light Yellow Hydrated powder
Purity:≥98%
Water：0.15%
Chloride：0.6%max

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Ziprasidone hydrochloride CAS:122883-93-6
Intermediates of Ziprasidone mesilatel CAS:199191-69-0
Intermediates of ZiprasidoneCAS:146939-27-7

Related News: Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.3-aminotiofeno-2-carboxilato de metilo CAS:22288-78-4 Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.potasio, 5-metil-1,3,4-oxadiazol-2-carboxilato CAS:888504-28-7 Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.1,3-fenilendiamina CAS:108-45-2 Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.